Abstract:CCR5 is a major co-receptor for HIV-1 entry into human cells and is also a good target for anti-HIV-1 drug design.Based on the chemical structure of Vicriviroc,a CCR5 antagonist,a series of new compounds were designed by changing its piperazine loop and other group substitutions.In the present study,15 bicyclic piperidine-based compounds were synthesized using a convergent synthetic route,and the structures of the target compounds were confirmed by MS and 1H-NMR.The synthetic routes were as follows:N-Boc-piperidine-4-carboxylic acid,N-Boc-pyrro-3-carboxylic acid and N-Boc-ethylenediamine were coupled with the amine derivatives to give the corresponding compounds 1a-1d,2a-2c,3a-3c,4-piperidinone hydrochloride reacted with 2,6-dimethylbenzoyl chloride,2,6-dichlorobenzoyl chloride and 2,4,6-trimethyl-5-pyrimidine carbonyl chloride to obtain the compounds 4a-4c.Then 4a-4c was reacted with 1a-1d,2a-2c,3a-3c to give the target compounds Ⅰ1-Ⅰ15.Furthermore,the antiviral activity and cell cytotoxicity of these compounds were evaluated with HIV-1 R5 strain in vitro.The results showed that all the target compounds exhibited potent antiviral activity against HIV-1 R5 strain(IC50=1.20-66.24 μmol · L-1).Preliminary analysis of the structure-activity relationship showed that some compounds with an aryl group and the 1,3-diamino-propane structure between two N atoms exhibited improved anti-HIV-1 activity.This study provides several clues for designing new anti-HIV-1 fusion inhibitors.

Forward- And Reverse-Synthesis Of Piperazinopiperidine Amide Analogs: A General Access To Structurally Diverse 4-Piperazinopiperidine-Based Ccr5 Antagonists

An Improved Synthesis of Piperazino-Piperidine Based CCR5 Antagonists with Flexible Variation on Pharmacophore Sites

Facile synthesis of 4-substituted-4-aminopiperidine derivatives, the key building block of piperazine-based CCR5 antagonists.

A Novel Asymmetric Synthesis of Cis-(3r, 4R)-N-(tert-butoxycarbonyl)-4-methyl-3-(methylamino) Piperidine

Facile Synthesis of 4‐substituted‐4‐aminopiperidine Derivatives, the Key Building Block of Piperazine‐Based CCR5 Antagonists.

Design, Syntheses, and Characterization of Piperazine Based Chemokine Receptor CCR5 Antagonists As Anti Prostate Cancer Agents.

Efficient Synthesis and Identification of Novel Propane-1,3-diamino Bridged CCR5 Antagonists with Variation on the Basic Center Carrier

Design, Synthesis, and Biological Evaluation of Novel Piperidine-4-carboxamide Derivatives As Potent CCR5 Inhibitors

Design, Synthesis and Biological Evaluation of Novel Piperazine Derivatives As CCR5 Antagonists

Design, Synthesis, and Biological Evaluation of Novel 2-Methylpiperazine Derivatives As Potent CCR5 Antagonists.

Design, Synthesis and Biological Activity of Bicyclic Piperidine-Based HIV-1 Inhibitors

Discovery and synthesis of 6,7,8,9-tetrahydro-5H-pyrido[4,3-c]azepin-5-one-based novel chemotype CCR2 antagonists via scaffold hopping strategy.

Synthesis and biological evaluation of novel piperidin-4-ol derivatives

Design, Synthesis, and Biological Activity of Novel 1,4-Disubstituted Piperidine/piperazine Derivatives As CCR5 Antagonist-Based HIV-1 Entry Inhibitors

Discovery of a Novel CCR5 Antagonist Lead Compound Through Fragment Assembly

Structure-Based Design of 1-Heteroaryl-1,3-propanediamine Derivatives As a Novel Series of CC-Chemokine Receptor 5 Antagonists.

ChemInform Abstract: Synthesis and Biological Evaluation of Novel Piperidin‐4‐ol Derivatives.

Design, Synthesis, and Biological Activity of Novel Octahydro-1H-pyrrolo[3,2-c]pyridine Derivatives As C-C Chemokine Receptor Type 5 (CCR5) Antagonists

Design and Synthesis of Tri‐substituted Chiral Pyrrolidin‐2‐one Derivatives As CCR4 Antagonists

Synthesis, biological evaluation and 3D-QSAR study of 1-(1,4-benzodioxan-2-ylcaronyl)-4-aryloxyalkyl-piperazines as α1-adrenoceptor antagonists

Discovery of novel (S)-alpha-phenyl-gamma-amino butanamide containing CCR5 antagonists via functionality inversion approach.